[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

G1 Therapeutics Inc (GTHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2018	12-2017	12-2016	12-2015	12-2006
Cash Flows From Operating Activities
Net Income	-85,288	-60,121	-30,291	-20,263	N/A
Depreciation Amortization	175	89	67	42	N/A
Other Working Capital	573	6,072	3,592	946	N/A
Other Operating Activity	10,233	3,441	1,491	5,430	0
Operating Cash Flow	$-74,307	$-50,519	$-25,141	$-13,845	$N/A

Cash Flows From Investing Activities
PPE Investments	-709	-294	-250	-87	N/A
Investing Cash Flow	$-709	$-294	$-250	$-87	$N/A

Cash Flows From Financing Activities
Common Stock Issued	341,386	108,718	7	53	N/A
Common Stock Repurchased	-892	-1,398	N/A	N/A	N/A
Other Financing Activity	0	0	49,751	33,123	0
Financing Cash Flow	$340,494	$107,320	$49,758	$33,176	$N/A

Beginning Cash Position	103,812	47,305	22,938	3,694	N/A
End Cash Position	369,290	103,812	47,305	22,938	N/A
Net Cash Flow	$265,478	$56,507	$24,367	$19,244	$N/A

Free Cash Flow
Operating Cash Flow	-74,307	-50,519	-25,141	-13,845	N/A
Capital Expenditure	-709	-294	-250	-87	N/A
Free Cash Flow	-75,016	-50,813	-25,391	-13,932	0